MktsMarkets

Travere Therapeutics, Inc.
NASDAQ: TVTXKey statistics
TVTX News
Stories mentioning TVTX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 127,199 | 129,688 | 164,859 | 114,449 | 81,732 | 74,787 | 62,898 | 54,116 |
| Cost of Goods Sold | 1,950 | 2,554 | 1,585 | 1,521 | 4,679 | 2,553 | 1,626 | 2,061 |
| Gross Profit | 125,249 | 127,134 | 163,274 | 112,928 | 77,053 | 72,234 | 61,272 | 52,055 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 80,254 | 114,120 | 86,453 | 76,216 | 60,413 | 69,501 | 65,619 | 64,776 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (36,915) | (32,431) | 24,931 | (12,650) | (42,674) | (60,737) | (56,149) | (67,704) |
| Interest Income | 2,584 | 2,592 | 3,047 | 3,287 | 3,795 | 3,795 | 3,570 | 4,420 |
| Interest Expense | ||||||||
| Other Expense | (91.00) | 11,068 | 487.00 | (526.00) | 549.00 | (581.00) | 520.00 | (3,495) |
| Pretax Income | (36,722) | (21,065) | 25,714 | (12,735) | (41,187) | (60,340) | (54,836) | (69,567) |
| Tax Provision | (120.00) | 921.00 | 8.00 | 20.00 | 39.00 | (72.00) | (84.00) | 85.00 |
| Net Income (Loss) | (37,102) | 2,729 | 25,706 | (12,755) | (41,226) | (60,264) | (54,811) | (70,409) |
| Earnings Per Share (Basic) | (0.40) | 0.03 | 0.29 | (0.14) | (0.47) | (0.76) | (0.70) | (0.91) |
| Earnings Per Share (Diluted) | (0.40) | 0.03 | 0.28 | (0.14) | (0.47) | (0.76) | (0.70) | (0.91) |
| Weighted Average Shares Outstanding (Basic) | 91,869 | 89,212 | 89,230 | 88,946 | 88,356 | 78,889 | 77,779 | 77,500 |
| Weighted Average Shares Outstanding (Diluted) | 91,869 | 89,212 | 102,619 | 88,946 | 88,356 | 78,889 | 77,779 | 77,500 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About TVTX
Travere Therapeutics, Inc. (NASDAQ: TVTX) is a stock listed on the Nasdaq Stock Market under the ticker symbol TVTX. It last traded at $51.56 (Nov 12, 2026, 9:30 AM ET), down 0.9% on the day. That gives Travere Therapeutics a market capitalisation of $4.7B.
Over the past 52 weeks TVTX has traded between $22.59 and $68.73.
Revenue for the quarter ended Mar 31, 2026 was $127.2M; a net loss of $37.1M. Revenue was up 55.6% from $81.7M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $127.2M | -$37.1M | -29.2% |
| Dec 31, 2025 | $129.7M | $2.7M | 2.1% |
| Sep 30, 2025 | $164.9M | $25.7M | 15.6% |
| Jun 30, 2025 | $114.4M | -$12.8M | -11.1% |
From Travere Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…